Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

p63 is essential for controlling epithelial stem cells and tissue health.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Skin reactions from cancer treatments might predict how well the treatments work.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Scalp cooling effectively reduces hair loss from chemotherapy.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.